Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes

<div>CPT1A is downregulated in KIRC and is associated with the overall survival rate of KIRC patients. (a) The scatterplot of CPT1A expression in the KIRC dataset of the TCGA database. (b) The survival curve of CPT1A obtained using the KIRC dataset of the TCGA database. (c) Typical immunohistochemical images of CPT1A in kidney cancer tissues and normal kidney tissues. (d) Scatterplot of the <svg height="8.68572pt" id="M16" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 11.0606 8.68572" width="11.0606pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M828 650H570L564 622C646 614 650 609 634 524L604 366H253L281 524C296 608 308 615 382 622L388 650H132L126 622C211 615 214 609 198 524L121 122C106 42 102 35 23 28L17 0H276L282 28C196 35 191 40 206 122L243 324H597L559 123C544 42 537 35 452 28L446 0H710L716 28C632 35 628 43 643 122L719 524C735 610 741 615 822 622L828 650Z"></path></g></svg> scores of CPT1A expression in 50 cancerous and normal kidney tissues. (e) Survival curve obtained based on the clinical data of kidney cancer patients collected by us.</div>

International Journal of Genomics

fig1

Figure 1

Figure 1: Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes 

Figure 1 | Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes 